Caeregen Therapeutics LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersTroy, MI
SAM.gov UEIZZY2CNNLJ2D1
Retinova Therapeutics is developing regenerative therapies for retinal ischemic diseases, specifically diabetic macular edema and retinal vein occlusion. The company's Noregen program, currently in late preclinical development, is designed to reverse vision loss caused by lack of blood flow to the retina and achieve regeneration of functional retinal tissue.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Caeregen Therapeutics LLC | Troy | MI | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.